Indication
Idiopathic parkinsonism
Idiopathic parkinsonism, commonly referred to as idiopathic Parkinson disease, is a chronic, progressive neurodegenerative movement disorder of unknown etiology primarily affecting the central nervous system in older adults. Read more about Idiopathic parkinsonism
735 drugs 257 manufacturers
Drugs that treat it
Common Idiopathic parkinsonism therapies.
CARBIDOPA-LEVODOPA-ENTACAPONE (carbidopa/levodopa/entacapone)
DIPHENHYDRAMINE HCL
CARBIDOPA
CARBIDOPA-LEVODOPA (carbidopa/levodopa)
AMANTADINE (amantadine HCl)
DIPHENHYDRAMINE HCL
ROPINIROLE HCL
SILADRYL (diphenhydramine HCl)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonIdiopathic parkinsonism, commonly referred to as idiopathic Parkinson disease, is a chronic, progressive neurodegenerative movement disorder of unknown etiology primarily affecting the central nervous system in older adults.
It is pathologically characterized by the degeneration of dopaminergic neurons within the substantia nigra pars compacta and the abnormal intraneuronal accumulation of alpha-synuclein into Lewy bodies.
Clinically, the condition is defined by asymmetric motor manifestations—most notably bradykinesia combined with resting tremor, cogwheel rigidity, and postural instability—often accompanied by nonmotor features such as autonomic dysfunction, sleep disturbances, and cognitive changes.
- nih.gov
Idiopathic parkinsonism, commonly referred to as idiopathic Parkinson disease, is a chronic, progressive neurodegenerative movement disorder of unknown etiology primarily affecting the central nervous system in older adults It is pathologically characterized by the degeneration of dopaminergic neurons within the substantia nigra pars compacta and the abnormal intraneuronal accumulation of alpha-synuclein into Lewy bodies
- nih.gov
Idiopathic parkinsonism, commonly referred to as idiopathic Parkinson disease, is a chronic, progressive neurodegenerative movement disorder of unknown etiology primarily affecting the central nervous system in older adults It is pathologically characterized by the degeneration of dopaminergic neurons within the substantia nigra pars compacta and the abnormal intraneuronal accumulation of alpha-synuclein into Lewy bodies Clinically, the condition is defined by asymmetric motor manifestations—mos...
- clevelandclinic.org
Clinically, the condition is defined by asymmetric motor manifestations—most notably bradykinesia combined with resting tremor, cogwheel rigidity, and postural instability—often accompanied by nonmotor features such as autonomic dysfunction, sleep disturbances, and cognitive changes
Personalize your experience
Follow Idiopathic parkinsonism and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.